BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29454317)

  • 41. Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Guérin.
    Liu X; Dowell AC; Patel P; Viney RP; Foster MC; Porfiri E; James ND; Bryan RT
    Future Oncol; 2014 Jun; 10(8):1443-56. PubMed ID: 25052754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer.
    Liu P; Chen S; Gao X; Liang H; Sun D; Shi B; Zhang Q; Guo H
    Front Immunol; 2022; 13():1032907. PubMed ID: 36225922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
    Gandhi NM; Morales A; Lamm DL
    BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.
    Langle YV; Belgorosky D; Prack McCormick B; Sahores A; Góngora A; Baldi A; Lanari C; Lamb C; Eiján AM
    J Urol; 2016 Jan; 195(1):188-97. PubMed ID: 26144336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort.
    Miyake M; Tatsumi Y; Gotoh D; Ohnishi S; Owari T; Iida K; Ohnishi K; Hori S; Morizawa Y; Itami Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Shimada K; Konishi N; Tanaka N; Fujimoto K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29048388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis.
    Mizushima T; Jiang G; Kawahara T; Li P; Han B; Inoue S; Ide H; Kato I; Jalalizadeh M; Miyagi E; Fukuda M; Reis LO; Miyamoto H
    Mol Cancer Ther; 2020 Sep; 19(9):1930-1942. PubMed ID: 32737155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.
    Kamat AM; Li R; O'Donnell MA; Black PC; Roupret M; Catto JW; Comperat E; Ingersoll MA; Witjes WP; McConkey DJ; Witjes JA
    Eur Urol; 2018 May; 73(5):738-748. PubMed ID: 29055653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma.
    Arnold J; de Boer EC; O'Donnell MA; Böhle A; Brandau S
    J Immunother; 2004; 27(2):116-23. PubMed ID: 14770083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder.
    Nunez-Nateras R; Castle EP; Protheroe CA; Stanton ML; Ocal TI; Ferrigni EN; Ochkur SI; Jacobsen EA; Hou YX; Andrews PE; Colby TV; Lee NA; Lee JJ
    Urol Oncol; 2014 Jan; 32(1):45.e23-30. PubMed ID: 24055426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.
    Alexandroff AB; Nicholson S; Patel PM; Jackson AM
    Immunotherapy; 2010 Jul; 2(4):551-60. PubMed ID: 20636008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
    Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H
    Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. H2O2 generation by bacillus Calmette-Guérin induces the cellular oxidative stress response required for bacillus Calmette-Guérin direct effects on urothelial carcinoma biology.
    Shah G; Zielonka J; Chen F; Zhang G; Cao Y; Kalyanaraman B; See W
    J Urol; 2014 Oct; 192(4):1238-48. PubMed ID: 24928267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    Jpn J Cancer Res; 2000 May; 91(5):534-42. PubMed ID: 10835499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycobacterium bovis bacille Calmette-Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy.
    Gellings P; Galeas-Pena M; Morici LA
    Clin Exp Med; 2023 Jun; 23(2):519-527. PubMed ID: 35076789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. γδ T Cells Support Antigen-Specific αβ T cell-Mediated Antitumor Responses during BCG Treatment for Bladder Cancer.
    Ji N; Mukherjee N; Shu ZJ; Reyes RM; Meeks JJ; McConkey DJ; Gelfond JA; Curiel TJ; Svatek RS
    Cancer Immunol Res; 2021 Dec; 9(12):1491-1503. PubMed ID: 34607803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells.
    Luo Y; Yamada H; Evanoff DP; Chen X
    Clin Exp Immunol; 2006 Oct; 146(1):181-8. PubMed ID: 16968412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of immunotherapy in bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer.
    Mukherjee N; Svatek RS; Mansour AM
    Urol Oncol; 2018 Mar; 36(3):103-108. PubMed ID: 29429897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.
    Hsu JW; Yin PN; Wood R; Messing J; Messing E; Lee YF
    Oncotarget; 2013 Dec; 4(12):2397-406. PubMed ID: 24353168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.